Our results demonstrate that hypoxia increases LRP1 expression through HIF-1α and that LRP1 overexpression mediates hypoxia-induced VLDL-CE uptake and accumulation in cardiomyocytes.
Background: Whether aging modifies mesenchymal stem cell (MSC) properties is unknown. Aim: To compare the differentiation capacity of human CD105 + MSCs obtained from young and elderly donors. Methods and results: Cells were obtained from young (n = 10, 24 T 6.4 years) and elderly (n = 9, 77 T 8.4 years) donors. Cell senescence was assessed by telomere length assays and lipofuscin accumulation. Cell pluripotentiality was analysed by adipogenic and osteogenic induction media, and myocyte phenotype was attempted with 5-azacytidine (5-AZ). Immunofluorescence, Western blot, transmission electron microscopy and fluo-4 confocal imaging were used to analyse the sarcomere, gap junctions and Ca 2+ dynamics. Cells obtained from young and elderly donors showed no significant differences in relative telomere length (40.1 T 6.4% and 40.3 T 3.6%, p = 0.9) and lipofuscin accumulation. Adipogenic and osteogenic potential of CD105 + MSCs was demonstrated. 5-AZ induced increased expression of sarcomeric proteins without complete sarcomere organization. Treated cells also showed increased presence of connexin-43 both in young and old donor-derived cells. Intercellular communications were verified by the observation of gap junctions and passage of Ca 2+ between neighbouring cells. Spontaneous Ca 2+ raises did not significantly increase after 5-AZ treatment in both age groups. Conclusion: Age does not influence the adipogenic and myogenic differentiation potential of human CD105 + MSCs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.